157 related articles for article (PubMed ID: 38223854)
1. Evaluation of Bivalirudin During Adult Extracorporeal Membrane Oxygenation: A Retrospective Characterization of Dosing, Efficacy and Bleeding.
Lopez ND; Seto SL; Barra ME; Roberts RJ; Rosovsky RP; Solomon EJ; Dalia A
Hosp Pharm; 2024 Feb; 59(1):77-85. PubMed ID: 38223854
[No Abstract] [Full Text] [Related]
2. Anticoagulation strategies in COVID-19 infected patients receiving ECMO support.
Diaz D; Martinez J; Bushman G; Wolowich WR
J Extra Corpor Technol; 2023 Sep; 55(3):121-129. PubMed ID: 37682210
[TBL] [Abstract][Full Text] [Related]
3. Use of bivalirudin for anticoagulation in pediatric extracorporeal membrane oxygenation (ECMO).
Kaushik S; Derespina KR; Chandhoke S; Shah DD; Cohen T; Shlomovich M; Medar SS; Peek GJ
Perfusion; 2023 Jan; 38(1):58-65. PubMed ID: 34318718
[TBL] [Abstract][Full Text] [Related]
4. Bivalirudin Anticoagulation Dosing Protocol for Extracorporeal Membrane Oxygenation: A Retrospective Review.
Netley J; Roy J; Greenlee J; Hart S; Todt M; Statz B
J Extra Corpor Technol; 2018 Sep; 50(3):161-166. PubMed ID: 30250342
[TBL] [Abstract][Full Text] [Related]
5. Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study.
Pieri M; Agracheva N; Bonaveglio E; Greco T; De Bonis M; Covello RD; Zangrillo A; Pappalardo F
J Cardiothorac Vasc Anesth; 2013 Feb; 27(1):30-4. PubMed ID: 23036625
[TBL] [Abstract][Full Text] [Related]
6. Correlation between partial thromboplastin time and thromboelastography in adult critically ill patients requiring bivalirudin for extracorporeal membrane oxygenation.
Buckley MS; Benanti GE; Meckel J; Tekle LA; Gilbert B; Puebla Neira D; McNierney DA; Korkames G; Yerondopoulos M; Park A; O'Hea JA; MacLaren R
Pharmacotherapy; 2023 Mar; 43(3):196-204. PubMed ID: 36759323
[TBL] [Abstract][Full Text] [Related]
7. Use of bivalirudin after initial heparin management among adult patients on long-term venovenous extracorporeal support as a bridge to lung transplant: A case series.
Halawi H; Harris JE; Goodarzi A; Yau S; Youssef JG; Botros M; Huang HJ
Pharmacotherapy; 2024 Mar; 44(3):283-289. PubMed ID: 38304955
[TBL] [Abstract][Full Text] [Related]
8. Bivalirudin Versus Unfractionated Heparin in Patients With Cardiogenic Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation.
Uricchio MN; Ramanan R; Esper SA; Murray H; Kaczorowski DJ; D'Aloiso B; Gomez H; Sciortino C; Sanchez PG; Sappington PL; Rivosecchi RM
ASAIO J; 2023 Jan; 69(1):107-113. PubMed ID: 35412480
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Bivalirudin for Therapeutic Anticoagulation in COVID-19 Patients Requiring ECMO Support.
Trigonis R; Smith N; Porter S; Anderson E; Jennings M; Kapoor R; Hage C; Moiz S; Garcia J; Rahman O
J Cardiothorac Vasc Anesth; 2022 Feb; 36(2):414-418. PubMed ID: 34782234
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of anticoagulation with bivalirudin for heparin-induced thrombocytopenia during extracorporeal membrane oxygenation.
Hanna DJ; Torbic H; Militello M; Strnad K; Krishnan S; Hohlfelder B
Int J Artif Organs; 2022 Aug; 45(8):688-694. PubMed ID: 35708334
[TBL] [Abstract][Full Text] [Related]
11. Description of Bivalirudin Use for Anticoagulation in Pediatric Patients on Mechanical Circulatory Support.
Campbell CT; Diaz L; Kelly B
Ann Pharmacother; 2021 Jan; 55(1):59-64. PubMed ID: 32590908
[TBL] [Abstract][Full Text] [Related]
12. Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation.
Kaseer H; Soto-Arenall M; Sanghavi D; Moss J; Ratzlaff R; Pham S; Guru P
J Card Surg; 2020 Apr; 35(4):779-786. PubMed ID: 32048330
[TBL] [Abstract][Full Text] [Related]
13. Comparison of bivalirudin versus heparin in adult extracorporeal membrane oxygenation anticoagulant therapy: A retrospective case-control study.
Tong Y; Rouzhahong J; Zhou W; Wang R; Wang Y; Ren Y; Guo J; Li Y; Wang Z; Song Y
Int J Artif Organs; 2023 Mar; 46(3):162-170. PubMed ID: 36600413
[TBL] [Abstract][Full Text] [Related]
14. [Application of argatroban in patients receiving extracorporeal membrane oxygenation support: a case-control study].
Zhang Z; Tang X; Wang R; Li X; Li Y; Tong Z; Sun B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Dec; 34(12):1305-1310. PubMed ID: 36567588
[TBL] [Abstract][Full Text] [Related]
15. Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study.
Cartwright B; Bruce HM; Kershaw G; Cai N; Othman J; Gattas D; Robson JL; Hayes S; Alicajic H; Hines A; Whyte A; Chaikittisilpa N; Southwood TJ; Forrest P; Totaro RJ; Bannon PG; Dunkley S; Chen VM; Dennis M
Sci Rep; 2021 Apr; 11(1):7975. PubMed ID: 33846433
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Bivalirudin as the Primary Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation for SARS-CoV-2-Associated Acute Respiratory Failure.
Bissell BD; Gabbard T; Sheridan EA; Baz MA; Davis GA; Ather A
Ann Pharmacother; 2022 Apr; 56(4):387-392. PubMed ID: 34323121
[TBL] [Abstract][Full Text] [Related]
17. Bivalirudin May Reduce the Need for Red Blood Cell Transfusion in Pediatric Cardiac Patients on Extracorporeal Membrane Oxygenation.
Machado DS; Garvan C; Philip J; Harrington D; Spiess B; Kelly B; Campbell CT; Pelletier JPR; Islam S; Peek GJ; Bleiweis MS
ASAIO J; 2021 Jun; 67(6):688-696. PubMed ID: 33031157
[TBL] [Abstract][Full Text] [Related]
18. Bivalirudin versus heparin anticoagulation in patients receiving extracorporeal membrane oxygenation.
Huang D; Guan Q; Qin J; Shan R; Wu J; Zhang C
Perfusion; 2023 Sep; 38(6):1133-1141. PubMed ID: 35616224
[TBL] [Abstract][Full Text] [Related]
19. Is bivalirudin an alternative anticoagulant for extracorporeal membrane oxygenation (ECMO) patients? A systematic review and meta-analysis.
Li DH; Sun MW; Zhang JC; Zhang C; Deng L; Jiang H
Thromb Res; 2022 Feb; 210():53-62. PubMed ID: 35007937
[TBL] [Abstract][Full Text] [Related]
20. Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation.
Ranucci M; Ballotta A; Kandil H; Isgrò G; Carlucci C; Baryshnikova E; Pistuddi V;
Crit Care; 2011; 15(6):R275. PubMed ID: 22099212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
